Effect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials

EY Seo, SH An, JH Cho, HS Suh… - Peritoneal Dialysis …, 2014 - journals.sagepub.com
Introduction Residual renal function (RRF) plays an important role in outcome of peritoneal
dialysis (PD) including mortality. It is, therefore, important to provide a strategy for the …

Association between dialysis modality and cardiovascular diseases: a comparison between peritoneal dialysis and hemodialysis

M Banshodani, H Kawanishi, M Moriishi, S Shintaku… - Blood …, 2020 - karger.com
Introduction: In patients with end-stage kidney disease (ESKD), cardiovascular diseases
(CVDs) are the most common causes of hospitalization and death. Objective: We aimed to …

The potential cardiovascular benefits of low-glucose degradation product, biocompatible peritoneal dialysis fluids: A review of the literature

CE Grantham, KL Hull… - Peritoneal Dialysis …, 2017 - journals.sagepub.com
Cardiovascular mortality in the end-stage renal disease (ESRD) population remains the
leading cause of death. Targeting traditional cardiovascular risk factors has proven …

Meta-analysis of individual patient data of sodium bicarbonate and sodium chloride for all-cause mortality after coronary angiography

JR Brown, DM Pearlman, EJ Marshall, SS Alam… - The American journal of …, 2016 - Elsevier
We sought to examine the relation between sodium bicarbonate prophylaxis for contrast-
associated nephropathy (CAN) and mortality. We conducted an individual patient data meta …

Prescription in peritoneal dialysis

G Amici, R Bergia, G Cancarini… - Journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Prescription in peritoneal dialysis Prescription in peritoneal dialysis J Nephrol. 2013 Nov-Dec:26
Suppl 21:83-95. doi: 10.5301/JN.2013.11635. Epub 2013 Nov 28. Authors Gianpaolo Amici 1 …

[引用][C] 腹膜透析液对腹膜纤维化的影响

林凡 - 国际泌尿系统杂志, 2012